Oxidation State in Peritoneal Dialysis in Patients with Type 2 Diabetes Mellitus

End-stage renal disease (ESRD) progression is closely related to oxidative stress (OS). The study objective was to determine the oxidant and antioxidant status in peritoneal dialysis (PD) patients with type 2 diabetes mellitus (DM). An analytical cross-sectional study from the PD program was carried out with 62 patients, 22 with and 40 without DM. Lipoperoxides (LPO) levels in patients with DM, 3.74 +/- 1.09 mM/L, and without DM, 3.87 +/- 0.84 mM/L were found to increase compared to healthy controls (HC) 3.05 +/- 0.58 mM/L (p = 0.006). The levels of the oxidative DNA damage marker (8-OH-dG) were found to be significantly increased in patients with DM, 1.71 ng/mL (0.19-71.92) and without DM, 1.05 ng/mL (0.16-68.80) front to 0.15 ng/mL (0.15-0.1624) of HC (p = 0.001). The antioxidant enzyme superoxide dismutase (SOD) activity was found to be significantly increased in patients with DM, 0.37 +/- 0.15 U/mL, and without DM, 0.37 +/- 0.17 compared to HC, 0.23 +/- 0.05 U/mL (p = 0.038). The activity of the enzyme glutathione peroxidase (GPx) showed a significant increase (p < 0.001) in patients with DM, 3.56 +/- 2.18 nmol/min/mL, and without DM, 3.28 +/- 1.46 nmol/min/mL, contrary to the activity obtained in HC, 1.55 +/- 0.34 nmol/min/mL. In conclusion, we found an imbalance of oxidative status in patients undergoing PD with and without DM through the significant increase in LPO oxidants and the marker of oxidative damage in DNA. The activity of the antioxidant enzymes SOD and GPx were significantly increased in patients with and without DM undergoing PD, possibly in an attempt to compensate for the deregulation of oxidants. Antioxidant enzymes could be promising therapeutic strategies as a complement to the management of chronic kidney diseases.

Automated summary

This study investigated the oxidative stress status in peritoneal dialysis patients with type 2 diabetes mellitus. The levels of lipoperoxides and oxidative DNA damage markers were found to be significantly increased in patients with and without diabetes, while the activity of antioxidant enzymes was also increased. Antioxidant enzymes could be a promising therapeutic strategy for the management of chronic kidney diseases.